AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis
Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs.
October 26, 2026
Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs.